Solutions
Transforming Pharma Market Access
Market access and commercial teams are not only responsible for the creation of payer and channel strategies to ensure that patients will have access to therapy, but also for the development and management of patient support services. This requires aligning the data from account management, payer marketing, and other commercial functions. If this data becomes siloed, projects can become mired in vendor data requests, manual data wrangling, and other sources of toil and delay.
The ICyte Platform is the only platform that unifies channel, patient, contracts and pricing, and gross-to-net data and applications for patient access and therapy commercialization. This allows for market access and commercial teams to have a better user experience backed by powerful insights that help remove access barriers to therapy, power financial data-driven decision-making, and increase infrastructure flexibility. These adaptable commercial solutions for life sciences address:
- Strong drug commercialization solutions and launch strategies that overcome market access challenges from the start
- Agile trade and channel solutions for a complete view into product utilization and availability, no matter the distribution strategy
- Visibility into downstream inventory availability
- Traditional siloed operations of market access operations by uniting insights from a wide range of contracting, channel, patient, financial, and pricing data
- Patient journey obstacles to develop patient initiation and patient adherence solutions
- Actionable insights from specialty pharmacy data
When all of your company’s data is managed within the ICyte platform, market access and commercial teams can quickly transform complex transactions across patient, payer, and channel data into actionable insights.
Market Access Strategy
IntegriChain’s managed pharma market access services and data science offerings supported by the ICyte platform enable manufacturers to transform their market access strategy by bringing together the financial, operational, and commercial data sets required to support therapy access in the era of specialty and precision medicine.
Launch Readiness
Whether it’s your first or 400th launch, pharma manufacturers can successfully implement a well-designed drug commercialization strategy and launch plan with help from IntegriChain. With the Icyte Platform, manufacturers are more likely to attain their revenue goals and outperform the competition.
Trade & Channel Insights
Whether your therapy is a brand, vaccine, orphan/rare, specialty, or biosimilar, IntegriChain helps manufacturers achieve channel agility and delivers accurate, timely insight into product utilization, availability, and channel performance.
Inventory Visibility
Widely accepted and validated by the audit community and leading finance teams, IntegriChain’s inventory analytics is the only source that marries actual supply chain data with the industry’s best non-projected prescription data source to estimate downstream inventory. Pharma manufacturers now have complete visibility into their pipeline.
Deeper Patient Insights
Market access teams need access to reliable, consistent, and timely patient data in order to quickly identify potential access obstacles, ensure initiation and adherence, and maximize product performance. IntegriChain can turn mountains of questionable patient data into actionable insights for you and your trading partners.
Specialty Pharmacy
IntegriChain’s specialty pharmacy (SP) analytics delivers diagnostic patient access insights by calibrating the datasets associated with a suite of business KPIs and analytics to reflect the uniqueness of your brand’s patient access.
ICyte Platform
Streamline pharma market access services and therapy commercialization solutions by quickly transforming patient, payer, complex transaction, and channel data into actionable insights through a single, unified platform.
